Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver

被引:10
作者
Allimant, Carole [1 ]
Deshayes, Emmanuel [2 ]
Kafrouni, Marilyne [3 ]
Santoro, Lore [2 ]
de Verbizier, Delphine [3 ]
Fourcade, Marjolaine [3 ]
Cassinotto, Christophe [1 ]
Hermida, Margaux [1 ]
Guillot, Chloe [1 ]
Mariano-Goulart, Denis [3 ]
Guiu, Boris [1 ]
机构
[1] St Eloi Univ Hosp, Dept Radiol, F-34000 Montpellier, France
[2] Inst Canc Montpellier, Dept Nucl Med, Montpellier, France
[3] Univ Hosp Montpellier, Dept Nucl Med, F-34000 Montpellier, France
关键词
selective internal radiation therapy; mebrofenin; hepatobiliary scintigraphy; liver; INTERNAL RADIATION-THERAPY; VOLUME; SPECT; SORAFENIB; TUMORS; TIME;
D O I
10.3390/diagnostics11060931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The functional changes that occur over time in the liver following Y-90-radioembolization (RE) using personalized dosimetry (PD) remain to be investigated. Methods: November 2016-October 2019: we retrospectively included hepatocellular carcinoma (HCC) patients treated by Y-90-glass RE using PD, who underwent hepatobiliary scintigraphy (HBS) at baseline and at 15 days, 1, 2, 3, and 6 months after RE. Results: There were 16 patients with unilobar disease (100%) included, and 64 HBS were performed. Whole liver function significantly decreased over time. The loss was maximal at 2 weeks: -32% (p = 0.002) and remained below baseline at 1 (-15%; p = 0.002), 2 (-25%; p < 0.001), and 3 months (-16%; p = 0.027). No radioembolization-induced liver disease was observed. Treated liver function strongly decreased to reach -64% (p < 0.001) at 2 months. Nontreated liver function decreased at 2 weeks (-21%; p = 0.027) and remained below baseline before reaching +20% (p = 0.002) and +59% (p < 0.001) at 3 and 6 months, respectively. Volumetric and functional changes exhibited parallel evolutions in the treated livers (p = 0.01) but independent evolutions in the nontreated livers (p = 0.08). Conclusion: RE using PD induces significant regional changes in liver function over time. As early as 15 days following RE, both the treated and nontreated livers showed a decreased function. Nontreated liver function recovered after 3 months and greatly increased afterwards.
引用
收藏
页数:12
相关论文
共 37 条
[1]   Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma [J].
Allimant, Carole ;
Kafrouni, Marilyne ;
Delicque, Julien ;
Ilonca, Diana ;
Cassinotto, Christophe ;
Assenat, Eric ;
Ursic-Bedoya, Jose ;
Pageaux, Georges-Philippe ;
Mariano-Goulart, Denis ;
Aho, Serge ;
Guiu, Boris .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (12) :1662-1670
[2]   Monitoring of total and regional liver function after SIRT [J].
Bennink, Roelof J. ;
Cieslak, Kasia P. ;
van Delden, Otto M. ;
van Lienden, Krijn P. ;
Klumpen, Heinz-Josef ;
Jansen, Peter L. ;
van Gulik, Thomas M. .
FRONTIERS IN ONCOLOGY, 2014, 4
[3]   Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients [J].
Braat, Manon N. G. J. A. ;
de Jong, Hugo W. ;
Seinstra, Beatrijs A. ;
Scholten, Mike V. ;
van den Bosch, Maurice A. A. J. ;
Lam, Marnix G. E. H. .
EJNMMI RESEARCH, 2017, 7
[4]   Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature [J].
Campigotto, Michele ;
Giuffre, Mauro ;
Colombo, Anna ;
Visintin, Alessia ;
Aversano, Alessandro ;
Budel, Martina ;
Masutti, Flora ;
Abazia, Cristiana ;
Croce, Lory Saveria .
WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (12) :1239-1257
[5]   Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on 99mTc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? [J].
Chapelle, Thiery ;
De Beeck, Bart Op ;
Huyghe, Ivan ;
Francque, Sven ;
Driessen, Ann ;
Roeyen, Geert ;
Ysebaert, Dirk ;
De Greef, Kathleen .
HPB, 2016, 18 (06) :494-503
[6]   SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma [J].
Chow, Pierce K. H. ;
Gandhi, Mihir ;
Tan, Say-Beng ;
Khin, Maung Win ;
Khasbazar, Ariunaa ;
Ong, Janus ;
Choo, Su Pin ;
Cheow, Peng Chung ;
Chotipanich, Chanisa ;
Lim, Kieron ;
Lesmana, Laurentius A. ;
Manuaba, Tjakra W. ;
Yoong, Boon Koon ;
Raj, Aloysius ;
Law, Chiong Soon ;
Cua, Ian H. Y. ;
Lobo, Rolley R. ;
Teh, Catherine S. C. ;
Kim, Yun Hwan ;
Jong, Yun Won ;
Han, Ho-Seong ;
Bae, Si-Hyun ;
Yoon, Hyun-Ki ;
Lee, Rheun-Chuan ;
Hung, Chien-Fu ;
Peng, Cheng-Yuan ;
Liang, Po-Chin ;
Bartlett, Adam ;
Kok, Kenneth Y. Y. ;
Thng, Choon-Hua ;
Low, Albert Su-Chong ;
Goh, Anthony S. W. ;
Tay, Kiang Hiong ;
Lo, Richard H. G. ;
Goh, Brian K. P. ;
Ng, David C. E. ;
Lekurwale, Ganesh ;
Liew, Wei Ming ;
Gebski, Val ;
Mak, Kenneth S. W. ;
Soo, Khee Chee .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) :1913-+
[7]   Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection [J].
Cieslak, Kasia P. ;
Bennink, Roelof J. ;
de Graaf, Wilmar ;
van Lienden, Krijn P. ;
Besselink, Marc G. ;
Busch, Olivier R. C. ;
Gouma, Dirk J. ;
van Gulik, Thomas M. .
HPB, 2016, 18 (09) :773-780
[8]   CELL-TYPES INVOLVED IN COLLAGEN AND FIBRONECTIN PRODUCTION IN NORMAL AND FIBROTIC HUMAN-LIVER [J].
CLEMENT, B ;
GRIMAUD, JA ;
CAMPION, JP ;
DEUGNIER, Y ;
GUILLOUZO, A .
HEPATOLOGY, 1986, 6 (02) :225-234
[9]   Increase in future remnant liver function after preoperative portal vein embolization [J].
de Graaf, W. ;
van Lienden, K. P. ;
van den Esschert, J. W. ;
Bennink, R. J. ;
van Gulik, T. M. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (06) :825-834
[10]   99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Functional Volume Before Partial Hepatectomy [J].
de Graaf, Wilmar ;
van Lienden, Krijn P. ;
van Gulik, Thomas M. ;
Bennink, Roelof J. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (02) :229-236